Trastuzumab-related palmar plantar erythrodysaesthesia.
L M
LM
Tho
N
N
Bose
L
L
Robertson
S
S
Bhattacharya
L
L
McClue
L
L
Anderson
E
E
Fraser
K
K
Graham
H
H
Yosef
G
G
Lumsden
D000368:Aged; D017311:Amlodipine / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000069059:Atorvastatin; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000188:drug therapy; D005260:Female; D005533:Foot Dermatoses / Q000139:chemically induced*; D006229:Hand Dermatoses / Q000139:chemically induced*; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D011758:Pyrroles / Q000627:therapeutic use; D000068878:Trastuzumab
D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D017311:Amlodipine; D000069059:Atorvastatin; D000068878:Trastuzumab